F. . Pirro, “Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy”, Dermatol Pract Concept, vol. 15, no. 1, p. 4838, Jan. 2025, doi: 10.5826/dpc.1501a4838.